Israeli pharmaceutical company Oramed Pharmaceuticals, which develops a pill for oral delivery of insulin for diabetics, has raised $4.6 million in a private placement. Oramed is developing a revolutionary tablet, which can be taken orally, and will save diabetics the hassle of injecting themselves with insulin. The funds raised will be directed towards further clinical trials of the pill.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts
Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024
TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024
Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024
BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments